Month: June 2012

FDA Actions Against Misleading Health Economic Promotions, 2002-2011

Boston, MA, USA – The study, “FDA Actions Against Health Economic Promotions, 2002-2011,” published in Value in Health, the official journal of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), investigated FDA regulatory actions against drug companies’ health economic promotions from

Posted in Health Policy Analyses, Value in Health Tagged with: , , ,

Pricing The Side Effects Of Prostate Cancer Treatment

Diemen, The Netherlands – Increased sharing of information across jurisdictions regarding the assessments of pharmaceuticals may save costs and reduce duplication of efforts.

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , ,

Do Patients Value Consulting A Prescribing Pharmacist?

Southampton, UK – A recent study originated by a joint partnership between the Universities of Southampton and Keele, UK has found that prescribing services provided by pharmacists are valued by respondents as an alternative to medical prescribing in primary care and

Posted in Preference-Based Assessments, Value in Health Tagged with: , , ,

Whose Values In Adolescent Health: Adults Or Adolescents?

Adelaide, South Australia – Differences between adolescents and adult values for assessing the health benefits of new medical interventions may be significant enough to impact upon health care policy.

Posted in Preference-Based Assessments, Value in Health Tagged with: , , ,